153 related articles for article (PubMed ID: 33902244)
1. [Diagnosis and progress in the progressive symmetric erythrokeratodermia].
Wang HJ; Lin ZM
Zhonghua Yi Xue Za Zhi; 2021 Apr; 101(16):1128-1131. PubMed ID: 33902244
[TBL] [Abstract][Full Text] [Related]
2. Striate Palmoplantar Keratoderma Showing Transgrediens in a Patient Harbouring Heterozygous Nonsense Mutations in Both DSG1 and SERPINB7.
Fukaura R; Takeichi T; Okuno Y; Kojima D; Kono M; Sugiura K; Suga Y; Akiyama M
Acta Derm Venereol; 2017 Mar; 97(3):399-401. PubMed ID: 27786350
[No Abstract] [Full Text] [Related]
3. No exonic mutations at GJB2, GJB3, GJB4, GJB6, ARS (Component B), and LOR genes responsible for a Chinese patient affected by progressive symmetric erythrokeratodermia with pseudoainhum.
Zhou F; Fu H; Liu L; Cui Y; Zhang Z; Chang R; Yue Z; Yang S; Zhang X
Int J Dermatol; 2014 Sep; 53(9):1111-3. PubMed ID: 24962725
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the absence of mutations at GJB3, GJB4 and LOR in progressive symmetrical erythrokeratodermia.
Wei S; Zhou Y; Zhang TD; Huang ZM; Zhang XB; Zhu HL; Liang BH; Lin L; Deng L
Clin Exp Dermatol; 2011 Jun; 36(4):399-405. PubMed ID: 21198793
[TBL] [Abstract][Full Text] [Related]
5. Erythrokeratodermia Variabilis-like Phenotype in Patients Carrying
Hotz A; Fölster-Holst R; Oji V; Bourrat E; Frank J; Marrakchi S; Ennouri M; Wankner L; Komlosi K; Alter S; Fischer J
Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540347
[TBL] [Abstract][Full Text] [Related]
6. Recessive progressive symmetric erythrokeratoderma results from a homozygous loss-of-function mutation of
Shah K; Ansar M; Mughal ZU; Khan FS; Ahmad W; Ferrara TM; Spritz RA
J Med Genet; 2017 Mar; 54(3):186-189. PubMed ID: 27965375
[TBL] [Abstract][Full Text] [Related]
7. Generalized erythematous plaques. Progressive symmetric erythrokeratodermia (PSEK) (erythrokeratodermia progressiva symmetrica).
Khoo BP; Tay YK; Tan SH
Arch Dermatol; 2000 May; 136(5):665, 668. PubMed ID: 10815862
[No Abstract] [Full Text] [Related]
8. Detection of SERPINB7 mutation can distinguish Nagashima-type palmoplantar keratoderma from other keratodermas with palmoplantar lesions.
Hashimoto T; Teye K; Numata S; Suga Y; Hamada T; Ishii N
Clin Exp Dermatol; 2017 Apr; 42(3):342-345. PubMed ID: 28211129
[No Abstract] [Full Text] [Related]
9. Two de novo GJA1 mutation in two sporadic patients with erythrokeratodermia variabilis et progressiva.
Li C; Liang J; Chen P; Zeng K; Xue R; Tian X; Liang L; Wang Q; Shi M; Zhang X
Mol Genet Genomic Med; 2019 Jun; 7(6):e670. PubMed ID: 30924322
[TBL] [Abstract][Full Text] [Related]
10. Erythrokeratodermia variabilis et progressiva.
Ishida-Yamamoto A
J Dermatol; 2016 Mar; 43(3):280-5. PubMed ID: 26945536
[TBL] [Abstract][Full Text] [Related]
11. Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree.
de Oliveira RTG; Christofolini DM; Criado PR; Lacaz Martins E; Kelsell D; Machado Filho CDS
Int J Dermatol; 2020 Jun; 59(6):722-725. PubMed ID: 32311086
[TBL] [Abstract][Full Text] [Related]
12. Progressive Nagashima-type palmoplantar keratosis in a Chinese patient with recurrent c.796C>T mutation in
Qiu M; Zou XB
Indian J Dermatol Venereol Leprol; 2017; 83(1):136. PubMed ID: 27506501
[No Abstract] [Full Text] [Related]
13. Two novel mutations of SERPINB7 in eight cases of Nagashima-type palmoplantar keratosis in the Chinese population.
Xiao T; Liu Y; Wang T; Ren J; Xia Y; Wang X
J Dermatol; 2022 May; 49(5):539-544. PubMed ID: 35178744
[TBL] [Abstract][Full Text] [Related]
14. Nagashima-type palmoplantar keratosis: a common Asian type caused by SERPINB7 protease inhibitor deficiency.
Kubo A
J Invest Dermatol; 2014 Aug; 134(8):2076-2079. PubMed ID: 25029323
[TBL] [Abstract][Full Text] [Related]
15. Spontaneous clinical remission of Nagashima-type palmoplantar keratoderma in a patient of Korean descent with a heterozygous SERPINB7 mutation.
Thakker S; Owusu-Agyei M; Marchalik R; Kang JK
Pediatr Dermatol; 2024; 41(2):369-371. PubMed ID: 38165066
[TBL] [Abstract][Full Text] [Related]
16. An unusual missense mutation in the GJB3 gene resulting in severe erythrokeratodermia variabilis.
Glatz M; van Steensel MA; van Geel M; Steijlen PM; Wolf P
Acta Derm Venereol; 2011 Oct; 91(6):714-5. PubMed ID: 21879244
[No Abstract] [Full Text] [Related]
17. Nagashima-type palmoplantar keratosis caused by biallelic maternal mutation of SERPINB7 with segmental uniparental disomy of chromosome 18q.
Hayakawa M; Tahara U; Ono N; Aoki S; Kawai T; Nakabayashi K; Hata K; Amagai M; Kubo A
J Dermatol; 2020 Dec; 47(12):e453-e454. PubMed ID: 32892407
[No Abstract] [Full Text] [Related]
18. Investigation of Nagashima-type palmoplantar keratoderma in China: A cross-sectional study of 234 patients.
Liu J; Chen Z; Hu L; Song Z; Mo R; Tsang LS; Liu Y; Huang X; Gong Z; Lin Z; Yang Y
J Dermatol; 2023 Mar; 50(3):375-382. PubMed ID: 36317385
[TBL] [Abstract][Full Text] [Related]
19. Dominant De Novo Mutations in GJA1 Cause Erythrokeratodermia Variabilis et Progressiva, without Features of Oculodentodigital Dysplasia.
Boyden LM; Craiglow BG; Zhou J; Hu R; Loring EC; Morel KD; Lauren CT; Lifton RP; Bilguvar K; Paller AS; Choate KA
J Invest Dermatol; 2015 Jun; 135(6):1540-1547. PubMed ID: 25398053
[TBL] [Abstract][Full Text] [Related]
20. Erythrokeratodermia variabilis et progressiva with a rare GJB3 mutation.
Imura K; Ikeya S; Ogata T; Tokura Y
J Dermatol; 2020 Apr; 47(4):e111-e113. PubMed ID: 31912549
[No Abstract] [Full Text] [Related]
[Next] [New Search]
